Filing Details
- Accession Number:
- 0001209191-20-000298
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-02 16:21:28
- Reporting Period:
- 2019-12-30
- Accepted Time:
- 2020-01-02 16:21:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1217420 | D William Young | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-30 | 30,000 | $65.65 | 39,311 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-30 | 7,402 | $218.05 | 31,909 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-12-30 | 21,798 | $218.93 | 10,111 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-12-30 | 500 | $220.25 | 9,611 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-12-30 | 300 | $221.16 | 9,311 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-30 | 30,000 | $0.00 | 30,000 | $65.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-05-06 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $218.05 (range $217.50 to $218.49).
- Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $218.93 (range $218.50 to $219.47).
- Open market sales reported on this line occurred at a weighted average price of $220.25 (range $219.90 to $220.73).
- Open market sales reported on this line occurred at a weighted average price of $221.16 (range $221.09 to $221.30).
- Fully vested.
Billionaire Hedge Funds
